The Biotech Age: The Business of Biotech and How to Profit From It [Paperback]

Richard L. Oliver (Author)

Book Description

ISBN-10: 0071414894 | ISBN-13: 978-0071414890 | Publication Date: March 24, 2003 | Edition: 2

A look at the forefront of an industry revolution

"I've been deep inside the biotech industry since its infancy. This book provides fresh insights about how it started, what drives it, and most importantly, where it's going."--Scott W. Morrison, partner, Ernst & Young LL

Richard W. Oliver predicted the onset of a new era with The Coming Biotech Age. Now that age is here--and companies are reaping the benefits of this incredible new revolution. As biotech companies become the new economic engines of growth and innovation, businesses must have access to the latest developments of this area of research.

In a special revised edition, now titled The Biotech Age, Oliver has created the first practical guide to this fascinating realm of scientific development. With updated information on the latest research, examples of biotech breakthroughs, and a close examination of current biotech issues such as cloning and stem cell research, The Biotech Age presents an accessible overview of the business of biotechnology and its vast implications and opportunities for all types of industries.

This is a topic no one can afford to miss--especially future-minded executives and investors in cutting-edge technologies.

Editorial Reviews

From the Back Cover

A nontechnical guide to the breakthrough business of biotech

"I've been deep inside the biotech industry since its infancy. This book provides fresh insights about how it started, what drives it, and most important, where it's going."--Scott W. Morrison, partner, Ernst & Young LLP

Richard W. Oliver predicted the onset of a new era in The Coming Biotech Age. That age is here. The biotech revolution is taking place within our leading universities, corporations, and government--which are becoming the new economic engines of growth and innovation. In less than a generation, Oliver asserts, virtually every company will be a "bioterials" company.

Now, in The Biotech Age, Oliver offers businesses access to the latest developments in this fast-moving, volatile industry. The Biotech Age is the first practical guide to the business of biotechnology, reflecting the rapid change experienced in various industries and the increasing effect that biotech is having on our lives. Oliver provides information on the latest research, examples of biotech breakthroughs, and a close examination of hot-button biotech issues, such as cloning and stem cell research. He addresses the new economic laws of biotech--eliminating the theory and jargon--and the vast implications and opportunities that biotech has for all types of industries, with remarkable technology that will take us further and faster than any before it. Oliver also outlines his version of our biotech future--revealing why developments in biotechnology are likely to have a more profound effect on the economy than the Information Age and the Industrial Age combined.

Putting you at the forefront of a revolution with a business potential almost unfathomable, The Biotech Age is a book no one can afford to miss.

About the Author

Dr. Richard W. Oliver is the author of the acclaimed The Shape of Things to Come and The Coming Biotech Age. He speaks and consults around the world on technology and business strategy. Oliver lives in Nashville, Tennessee.

Product Details

• Paperback: 253 pages
• Publisher: McGraw-Hill; 2 edition (March 24, 2003)
• Language: English
• ISBN-10: 0071414894
• ISBN-13: 978-0071414890
• Product Dimensions: 9.1 x 6 x 0.7 inches
• Shipping Weight: 12.3 ounces (View shipping rates and policies)
• Average Customer Review: 4.5 out of 5 stars  See all reviews (2 customer reviews)
• Amazon Best Sellers Rank: #1,616,380 in Books (See Top 100 in Books)

More About the Author

Discover books, learn about writers, read author blogs, and more.

Customer Reviews

Most Helpful Customer Reviews

5.0 out of 5 stars Good Book, November 19, 2007

By 

The PM Doc - See all my reviews

This review is from: The Biotech Age: The Business of Biotech and How to Profit From It (Paperback)

This is a good book on the business aspect of biotechnology. If you are relatively new to the business of biotech, this book is a good start.

1 of 2 people found the following review helpful:

4.0 out of 5 stars I'm an agronomist, than four stars, September 2, 2007

By 

Dalton C. Rocha (Fortaleza, CE, Brazil.) - See all my reviews

Amazon Verified Purchase

This review is from: The Biotech Age: The Business of Biotech and How to Profit From It (Paperback)

I read this good book, here in Brazil.Richard W. Oliver , the author of this good book, made a good work, writing this book.
Even so, this book has some failures.To example, on page 109 the author writes:"The effforts aimed at "improving" the gene pool of humans, through, that came to be known as eugenics, were not so universally accepted.Eugenics enjoyed a brief spate of popularity in the United States and were favored by the rich and famous.Hitler's action to "cleanse" the German populace pretty much ended the eugenics movement in the middle of this century."
In fact, the period of eugenics' popularity in yhe USA, wasn't "brief", but very long.American eugenics began in 1860 decade or even earlier and in fact, eugenics became on decadency in USA, during the Third Reich between the years 1933 and 1945.An american who was born in 1860 was 80 years old in 1940.And this very old man, had lived 100% of his life, under eugenics' popularity.Not only rich and famous americans were eugenics' supporters, but also rabins, pastors, politicians and general public.United States had the first eugenics law in 1907.Third Reich came only in 1933.
The failures of this book really exists, but they are rare.Four stars for this book.